M1FG
BLFS icon

Mach-1 Financial Group’s BioLife Solutions BLFS Stock Holding History

Mach-1 Financial Group’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,958
Closed -$301K – 268
2025
Q2 		$301K Buy
13,958
+1,193
+9% +$26.9K 0.09% 205
2025
Q1 		$292K Buy
+12,765
New +$336K 0.09% 200

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Mach-1 Financial Group's BLFS Position: Q3 2025 in Review

Mach-1 Financial Group sold out of BioLife Solutions (BLFS) in Q3 2025, closing a stake of 13,958 shares — an estimated $301K sold.

Mach-1 Financial Group first reported a position in BLFS in Q1 2025 and held it in 2 quarters. The position peaked at $301K in Q2 2025. 192 funds tracked by Wall St. Rank hold BLFS as of Q3 2025.

  • Mach-1 Financial Group reported no remaining BioLife Solutions position as of Q3 2025 after selling out during the quarter.
  • Mach-1 Financial Group sold 13,958 BioLife Solutions shares in Q3 2025, an estimated $301K.
  • Mach-1 Financial Group first reported a position in BioLife Solutions in Q1 2025 and held it in 2 quarters.
  • Mach-1 Financial Group's BioLife Solutions position peaked at $301K in Q2 2025.
  • 192 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2025.

Based on Mach-1 Financial Group's 13F filing for Q3 2025, filed 12 Nov 2025.